Pay in 4 interest-free payments of $7.07 Learn more
Ships within 48 hours · Estimated delivery Sep 4 - Sep 9
Statements Data availability statement The datasets presented in the study can be found in online repositories
These are usually temporary and should ease up as your body gets used to the medication
Anti-obesity (AOM) GLP-1 prescriptions skew very heavily to the Commercial channel (81%), while anti-diabetic GLP-1s show a more balanced distribution: a smaller proportion of Commercial claims than AOM GLP-1s but a notably larger proportion than SGLT2s
Mild side effects like nausea or digestive discomfort can occur, but these are usually temporary and manageable
This finding is crucial for patients aiming to manage their diabetes more effectively with fewer medications
US$ 22.38
US$ 20.12
US$ 22.37
US$ 20.64
US$ 20.16
